Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

Kem P Krueger, A Christie NelsonSchool of Pharmacy, University of Wyoming, Laramie, WY, USAAbstract: Invasive aspergillosis is a life-threatening fungal infection predominately affecting immunocompromised individuals. The incidence of inpatient-treated aspergillosis cases in the US is estimated to b...

Full description

Bibliographic Details
Main Authors:	Kem P Krueger, A Christie Nelson
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-08-01
Series:	ClinicoEconomics and Outcomes Research
Online Access:	http://www.dovepress.com/economic-considerations-in-the-treatment-of-invasive-aspergillosis-a-r-a3433

Similar Items

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
by: Karthaus M
Published: (2011-04-01)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
by: Sandherr M, et al.
Published: (2011-04-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

An Economic Evaluation of Voriconazole versus Amphotericin B for the Treatment of Invasive Aspergillosis in Canada
by: Coleman Rotstein, et al.
Published: (2004-01-01)

Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation
by: V. I. Ignatieva, et al.
Published: (2015-06-01)

The first study of plasma voriconazole concentration in Thai patient with invasive aspergillosis
by: M. Chayakulkeeree, et al.
Published: (2014-04-01)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment
by: Derek H. Ohlstein, et al.
Published: (2012-02-01)

Management of invasive aspergillosis in patients with COPD: rational use of voriconazole
by: Florence Ader, et al.
Published: (2009-07-01)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
by: Grau S, et al.
Published: (2016-12-01)

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
by: Lefteris Floros, et al.
Published: (2019-02-01)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
by: Martínez-Casanova J, et al.
Published: (2018-03-01)

Relationship between voriconazole trough concentration and liver injury in elderly patients with lung invasive aspergillosis
by: CHENG Lin, et al.
Published: (2020-10-01)

Paradoxical Response after a Voriconazole Treatment in an Immunocompetent Host with a Skull Base Osteomyelitis due to Invasive Aspergillosis
by: Jeong-Min Kim, et al.
Published: (2017-12-01)

Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
by: Ronald Olum, et al.
Published: (2020-01-01)

Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy
by: Rinaldo Focaccia Siciliano, et al.
Published: (2012-01-01)

Pharmacoeconomic considerations in the treatment of breast cancer
by: Athanasios Pallis, et al.
Published: (2010-06-01)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
by: Rémy Nyga, et al.
Published: (2019-03-01)

Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
by: Louis Yi Ann Chai, et al.
Published: (2014-01-01)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
by: Ferguson MJ, et al.
Published: (2017-09-01)

Determination of Voriconazole Plasma Concentration by HPLC Technique and Evaluating Its Association with Clinical Outcome and Adverse Effects in Patients with Invasive Aspergillosis
by: Sahar Yousefian, et al.
Published: (2021-01-01)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
by: Taotao Wang, et al.
Published: (2018-06-01)

Invasive trichosporonosis treated with voriconazole
by: Vaibhav Garg, et al.
Published: (2018-05-01)

Micafungin in the treatment of invasive candidiasis and invasive aspergillosis
by: Nathan P Wiederhold, et al.
Published: (2009-01-01)

Diagnostic Approaches for Invasive Aspergillosis—Specific Considerations in the Pediatric Population
by: Thomas Lehrnbecher, et al.
Published: (2018-03-01)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from A Tertiary Care Centre in India
by: Nitin Gupta, et al.
Published: (2020-08-01)

Toward the personalized and integrative management of voriconazole dosing during COVID-19-associated pulmonary aspergillosis
by: Brendan Le Daré, et al.
Published: (2021-04-01)

Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults
by: Coleman Rotstein, et al.
Published: (2008-01-01)

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS
by: A.S. Kolbin, et al.
Published: (2011-08-01)

PHARMACOECONOMIC ANALYSIS OF MICAFUNGIN USING IN THE TREATMENT OF INVASIVE CANDIDIASIS IN NEWBORNS
by: A.S. Kolbin, et al.
Published: (2011-08-01)

Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole
by: Uluhan Sili, et al.
Published: (2015-06-01)

INVASIVE ASPERGILLOSIS IN AN ADOLESCENT
by: M. E. Makogonova, et al.
Published: (2017-03-01)

Need for pharmacoeconomic consideration of antiepileptic drugs monotherapy treatment in persons with epilepsy
by: Sudhir C. Sarangi, et al.
Published: (2020-10-01)

A case of treatment with voriconazole for chronic progressive pulmonary aspergillosis in a patient receiving tacrolimus for dermatomyositis-associated interstitial lung disease
by: Eisuke Mochizuki, et al.
Published: (2015-01-01)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
by: Donnelley MA, et al.
Published: (2016-06-01)

Invasive tracheal aspergillosis after chemoradiotherapy treatment
by: Shok Yin Lee, et al.
Published: (2019-10-01)

Pediatric Invasive Aspergillosis
by: Rachel L. Wattier, et al.
Published: (2016-06-01)

Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags
by: Andréa I.H. Adams, et al.

Update on the optimal use of voriconazole for invasive fungal infections
by: Asma Lat George R Thompson III
Published: (2011-02-01)

Inhaled voriconazole formulations for invasive fungal infections in the lungs
by: Beinborn, Nicole Angela
Published: (2013)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Cannot write session to /tmp/vufind_sessions/sess_vhjgfcdf0quomanl422ik5mm70